Association of Dynamic Changes in Metabolic Syndrome Status with the Risk of Parkinson's Disease: A Nationwide Cohort Study

被引:9
作者
Park, Sang Hyun [1 ]
Nam, Ga Eun [2 ]
Han, Kyungdo [3 ]
Huh, Youn [4 ]
Kim, Wonsock [4 ]
Lee, Min-Kyung [5 ]
Koh, Eun-Sil [6 ]
Kim, Eun Sook [7 ]
Kim, Mee Kyung [8 ]
Kwon, Hyuk-Sang [8 ]
Kim, Seon Mee [2 ]
Cho, Kyung Hwan [2 ]
Park, Yong Gyu [9 ]
机构
[1] Catholic Univ Korea, Grad Sch, Dept Biomed & Hlth Sci, Seoul, South Korea
[2] Korea Univ, Dept Family Med, Coll Med, Seoul, South Korea
[3] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea
[4] Eulji Univ, Uijeongbu Eulji Med Ctr, Dept Family Med, Gyeonggi Do, South Korea
[5] Hanyang Univ, Myongji Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Gyeonggi Do, South Korea
[6] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Nephrol,Yeouido St Marys Hosp, Seoul, South Korea
[7] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Incheon St Marys Hosp, Incheon, South Korea
[8] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Yeouido St Marys Hosp, Seoul, South Korea
[9] Catholic Univ Korea, Coll Med, Dept Med Lifesci, 222 Banpo Daero, Seoul 06591, South Korea
基金
新加坡国家研究基金会;
关键词
Metabolic syndrome; Parkinson's disease; metabolic change; cohort; INSULIN-RESISTANCE; ALZHEIMERS; NEURODEGENERATION; HYPERTENSION; MORTALITY; OBESITY; MASS;
D O I
10.3233/JPD-212589
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The longitudinal association between dynamic changes in the metabolic syndrome (MS) status and Parkinson's disease (PD) has been poorly studied. Objective: We examined whether dynamic changes in MS status are associated with altered risk for PD. Methods: This study was a nationwide retrospective cohort study. We enrolled 5,522,813 individuals aged >= 40 years who had undergone health examinations under the National Health Insurance Service between 2009 and 2010 (two health examinations with a 2-year interval). Participants were followed up until the end of 2017. The participants were categorized into four groups according to MS status changes over 2 years: non-MS, improved MS, incident MS, and persistent MS groups. Multivariable Cox hazard regression was performed. Results: During the 7-year median follow-up, there were 20,524 cases of newly developed PD. Compared with non-MS group, improved, incident, and persistent MS groups for 2 years were significantly associated with higher risks of PD (model 3; hazard ratio: 1.12, 95% confidence interval: 1.06-1.19 [improved MS]; 1.15, 1.09-1.22 [incident MS]; and 1.25, 1.20-1.30 [persistent MS]). Individuals with incident and persistent abdominal obesity, low levels of high-density lipoprotein cholesterol, hypertriglyceridemia, and hyperglycemia had a significantly increased risks of PD compared with those without either condition over 2 years. Conclusion: Persistent and incident MS and its components may be risk factors for incident PD. Ever exposure to MS may also be associated with PD risk. Appropriate intervention for preventing and improving MS may be crucial in decreasing the PD incidence.
引用
收藏
页码:1751 / 1759
页数:9
相关论文
共 35 条
  • [1] Cardioprotective effects of light-moderate consumption of alcohol: A review of putative mechanisms
    Agarwal, DP
    [J]. ALCOHOL AND ALCOHOLISM, 2002, 37 (05): : 409 - 415
  • [2] Insulin resistance and Parkinson's disease: A new target for disease modification?
    Athauda, D.
    Foltynie, T.
    [J]. PROGRESS IN NEUROBIOLOGY, 2016, 145 : 98 - 120
  • [3] Parkinson's disease, insulin resistance and novel agents of neuroprotection
    Aviles-Olmos, Iciar
    Limousin, Patricia
    Lees, Andrew
    Foltynie, Thomas
    [J]. BRAIN, 2013, 136 : 374 - 384
  • [4] Dementia is associated with Insulin Resistance in patients with Parkinson's Disease
    Bosco, Domenico
    Plastino, Massimiliano
    Cristiano, Dario
    Colica, Carmela
    Ermio, Caterina
    De Bartolo, Matteo
    Mungari, Pasquale
    Fonte, Giulia
    Consoli, Domenico
    Consoli, Arturo
    Fava, Antonietta
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 315 (1-2) : 39 - 43
  • [5] Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors
    Bosy-Westphal, A
    Geisler, C
    Onur, S
    Korth, O
    Selberg, O
    Schrezenmeir, J
    Müller, MJ
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2006, 30 (03) : 475 - 483
  • [6] The Metabolic Syndrome
    Cornier, Marc-Andre
    Dabelea, Dana
    Hernandez, Teri L.
    Lindstrom, Rachel C.
    Steig, Amy J.
    Stob, Nicole R.
    Van Pelt, Rachael E.
    Wang, Hong
    Eckel, Robert H.
    [J]. ENDOCRINE REVIEWS, 2008, 29 (07) : 777 - 822
  • [7] de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45
  • [8] Serum cholesterol levels and the risk of Parkinson's disease
    de lau, Lonneke M. L.
    Koudstaal, Peter J.
    Hofman, Albert
    Breteler, Monique M. B.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (10) : 998 - 1002
  • [9] Epidemiology of Parkinson's disease
    de Lau, Lonneke M. L.
    Breteler, Monique M. B.
    [J]. LANCET NEUROLOGY, 2006, 5 (06) : 525 - 535
  • [10] Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
    Dorsey, E. R.
    Constantinescu, R.
    Thompson, J. P.
    Biglan, K. M.
    Holloway, R. G.
    Kieburtz, K.
    Marshall, F. J.
    Ravina, B. M.
    Schifitto, G.
    Siderowf, A.
    Tanner, C. M.
    [J]. NEUROLOGY, 2007, 68 (05) : 384 - 386